Exhibit 10.66


 


OMB Approval
0990-0115


 


	
   

  	
  1.               THIS CONTRACT IS A RATED ORDER

  	
  RATING

  	
  PAGE OF PAGES

  
	
  AWARD/CONTRACT

  	
  UNDER DPAS (15 CFR 350)                               

  	
  N/A

  	
  1

  	
  45

  
	
   

  	
   

  	
   

  
	
  2.               CONTRACT (Proc. Inst. Ident.) NO.

  HHSN272200800063C

  	
  3.               EFFECTIVE DATE

  September 30, 2008

  	
  4.               REQUISITION/PURCHASE REQUEST/PROJECT NO.

  750904

  
	
   

  	
   

  	
   

  
	
  5.               ISSUED BY

  	
  CODE

  	
   

  	
  6.               ADMINISTERED BY (If
  other than Item 6)

  	
  CODE

  
	
  Office of
  Acquisitions, DEA

  National Institute of Allergy and Infectious Diseases

  National Institutes of Health, DHHS

  6700-B Rockledge Dr., Room 3214, MSC 7612

  Bethesda, Maryland 20892-7612

  	
   

  AIDS RCB



  RFP NUMBER:
  NIH-NIAID-DAIDS-BAA-08-16

  NIAID Contract # N01-AI-80063

  
	
   

  	
   

  
	
  7.               NAME AND ADDRESS OF CONTRACTOR (No. street, county, state and ZIP Code)

  	
  8.               DELIVERY

  
	
   

  	
  o 
  FOB ORIGIN

  	
  x  OTHER (See below)

  FOB Destination

  
	
   

  	
   

  	
   

  
	
  VGX
  Pharmaceuticals, Inc.

  	
  VIN#1150944

  	
  9.               DISCOUNT FOR PROMPT PAYMENT

  
	
  450 Sentry
  Parkway East

  	
  N/A

  
	
  Blue Bell,
  Pennsylvania 19422

  	
   

  
	
   

  	
  10.          SUBMIT INVOICES

  	
  ITEM

  
	
   

  	
   

  	
   

  
	
  CODE

  	
  FACILITY CODE

  	
  ADDRESS SHOWN IN:

  	
  Art. G.3.

  
	
   

  	
   

  	
   

  	
   

  
	
  11.  SHIP
  TO/MARK FOR

  	
  CODE

  	
  N/A

  	
  12.   PAYMENT
  WILL BE MADE BY

  	
  CODE

  	
  N/A

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
    Article
  F.1.

  	
   

  	
   

  	
    See
  Article G.3.

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  13.         AUTHORITY FOR USING OTHER FULL AND OPEN
  COMPETITION:

  	
  14.         ACCOUNTING AND APPROPRIATION DATA

  
	
   

  	
   

  	
  TIN# 51-0404886

  	
  SOC 25.55

  	
  DUNS 063784784

  
	
  o 
  10 U.S.C. 2304(c)(     )

  	
  o 
  41 U.S.C. 253(c)(     )

  	
  CAN 8-8470035

  	
  $4,663,588

  	
   

  
															



 


	
  15A.          ITEM NO.

  	
  15B.           SUPPLIES/SERVICES

  	
  15C.  QUANTITY

  	
  15D.  UNIT

  	
  15E.  UNIT PRICE

  	
  15F.  AMOUNT

  
	
  Title: HIV Vaccine
  Design and Development Teams project Entitled “Development of Improved DNA
  Vaccines and Electroporation Delivery Devices for HIV Prophylactic HIV
  Vaccines”

   

   

  Period:  September 30, 2008 through September 29,
  2015

  Contract Type: Cost
  Reimbursement with Options (Completion)

  	
   

  	
   

  	
  FY 08 Base

  FY 09 Option

  FY 10 Option

  FY 11 Option

  FY 12 Option

  FY 14 Option

  FY 15 Option

  	
  $4,663,588

  $6,573,776

  $5,258,144

  $2,717,534

  $2,056,112

  $1,193,230

  $1,132,465

  
	
   

  	
  15G.    
  TOTAL AMOUNT OF CONTRACT        

  	
  $23,594,849

  
	
   

  	
   

  	
   

  
	
  16.  TABLE OF CONTENTS

  



 


	
  x

  	
  SEC.

  	
  DESCRIPTION

  	
  PAGE(S)

  	
  x

  	
  SEC.

  	
  DESCRIPTION

  	
  PAGE(S)

  
	
  PART I - THE SCHEDULE

  	
  PART II - CONTRACT
  CLAUSES

  
	
  x

  	
  A

  	
  SOLICITATION/CONTRACT FORM

  	
  1

  	
  x

  	
  I

  	
  CONTRACT CLAUSES

  	
  35

  
	
  x

  	
  B

  	
  SUPPLIES OR SERVICES AND PRICE/COST

  	
  4

  	
  PART III - LIST OF
  DOCUMENTS, EXHIBITS AND OTHER ATTACH.

  
	
  x

  	
  C

  	
  DESCRIPTION/SPECS./WORK STATEMENT

  	
  12

  	
  x

  	
  J

  	
  LIST OF ATTACHMENTS

  	
  44

  
	
  x

  	
  D

  	
  PACKAGING AND MARKING

  	
  17

  	
  PART IV -
  REPRESENTATIONS AND INSTRUCTIONS

  
	
  x

  	
  E

  	
  INSPECTION AND ACCEPTANCE

  	
  18

  	
  x

  	
  K

  	
  REPRESENTATIONS, CERTIFICATIONS AND

  	
  45

  
	
  x

  	
  F

  	
  DELIVERIES OR PERFORMANCE

  	
  19

  	
   

  	
   

  	
  OTHER STATEMENTS OF OFFERORS

  	
   

  
	
  x

  	
  G

  	
  CONTRACT ADMINISTRATION DATA

  	
  22

  	
  o

  	
  L

  	
  INSTRS., CONDS., AND NOTICES TO OFFERORS

  	
   

  
	
  x

  	
  H

  	
  SPECIAL CONTRACT REQUIREMENTS

  	
  26

  	
  o

  	
  M

  	
  EVALUATION FACTORS FOR AWARD

  	
   

  



 


	
  CONTRACTING
  OFFICER WILL COMPLETE ITEM 17 OR 18 AS APPLICABLE

  
	
   

  
	
  17.  x CONTRACTOR’S NEGOTIATED AGREEMENT (Contractor is required to sign this document and
  return            copies to
  issuing office.)  Contractor
  agrees to furnish and deliver all items or perform all the services set forth
  or otherwise identified above and on any continuation sheets for the
  consideration stated herein.  The
  rights and obligations of the parties to this contract shall be subject to
  and governed by the following documents: 
  (a) this award/contract, (b) the solicitation, if any, and (c) such
  provisions, representations, certifications, and specifications, as are
  attached or incorporated by reference herein. 
  (Attachments are listed herein.)

  	
   

  	
  18.  o  AWARD  (Contractor is not required to sign this document.)  Your offer on Solicitation Number                                            ,
  including the additions or changes made by you which additions or changes are
  set forth in full above, is hereby accepted as to the items listed above and
  on any continuation sheets.  This award
  consummates the contract which consists of the following documents:  (a) the Government’s solicitation and your
  offer, and (b) this award/contract.  No
  further contractual document is necessary.

  
	
   

  	
   

  
	
  19A.          NAME AND TITLE OF SIGNER   (Type or print)

  	
  20A.          NAME OF CONTRACTING OFFICER

  
	
  NIRANJAN Y. SARDESAI, SR.
  VP, R&D

  	
  Eileen D. Webster-Cissel

  Contracting Officer, Office of Acquisitions, DEA, NIAID, NIH, DHHS 

  
	
   

  	
   

  
	
  19B.           NAME OF CONTRACTOR

  	
  19C.           DATE SIGNED

  	
  20B.           UNITED STATES OF AMERICA

  	
  20C.           DATE SIGNED

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  9/25/08

  	
   

  	
  9/26/08

  
	
  VGX Pharmaceuticals,
  Inc.   /S/Niranjan Y. Sardesai

  	
   

  	
  BY

  	
  /s/ Eileen D. Webster-Cissel

  	
   

  
	
  (Signature
  of person authorized to sign)

  	
   

  	
  (Signature of Contracting
  Officer)

  	
   

  
							



 


	
  NSN
  7540-01-152-8069

  	
  26-107

  	
  STANDARD
  FORM 26 (REV. 4-85)

  
	
  PREVIOUS EDITION
  UNUSABLE

  	
  Computer Generated

  	
  Prescribed by GSA

  
	
   

  	
   

  	
  FAR (48 CFR)
  53.214(a)